News Related to TB and Swaziland

>>News Related to TB and Swaziland

REDUCING TB DELAYS: EVALUATING THE FREQUENCY AND CAUSES OF DELAYS IN BANGLADESH AND SWAZILAND

In 2011-2012, TB CARE II undertook a study to understand TB patients’ delays and inform the development of an integrated set of recommendations for TB program managers and service providers regarding the appropriateness of different strategies for reducing patient factor delays in accessing TB diagnostic and treatment services. The project, led by URC, developed

TB CARE II INTRODUCES TOOLKIT TO ADDRESS TIMELY TB CASE DETECTION AND TREATMENT

An effective tuberculosis (TB) control program requires early diagnosis and immediate initiation into treatment to reduce transmission.  In 2011, recognizing this fact, the USAID funded TB CARE II Project developed a framework for analyzing TB delay along with a set of tools to collect data on patient delays. TB CARE II then conducted field

Isoniazid Preventative Therapy (IPT) in Swaziland

Isoniazid Preventative Therapy (IPT) is a highly effective tuberculosis (TB) prevention method for people living with HIV, with a 33-64% reduction in TB in HIV+ patients who completed IPT. This benefit is enhanced to an 80-95% reduction when IPT is combined with proper anti-retroviral therapy (ART). Despite this clear and tangible benefit, global uptake

URC Participation at the 48th Annual Union World Conference on Lung Health

The Union World Conference on Lung Health continues to be the largest gathering of clinicians and public health professionals, program managers, policymakers, researchers, and advocates working to end the suffering caused by TB and other lung diseases. The 48th annual conference, held in Guadalajara, Mexico on October 11-14, 2017, continued this tradition with fruitful

Chat with TB CARE II
Powered by TB CARE II